Skin Pathology
Pigment disorders cover conditions with too much, too little, or altered distribution of pigment. This guide summarizes the major types, their pathology, diagnostic clues, and practical management points — focused on clarity and clinical relevance.
🔄 Quick overview
Skin colour is determined by melanin production, melanosome transfer, melanocyte number/function, and dermal deposition of pigment. Disorders arise from increased melanin, loss of melanocytes, abnormal melanocyte function, or exogenous/drug-induced pigments.
Main categories
- Hyperpigmentation (local or diffuse)
- Hypopigmentation and depigmentation
- Mixed/patchy disorders and mosaic patterns
- Exogenous or drug-induced pigmentation
Why pathology matters
- Biopsy can show melanocyte loss vs decreased melanin, dermal melanosis, or deposition of abnormal pigment (e.g., hemosiderin).
- Histology guides prognosis and treatment choices (e.g., inflammatory vitiligo may respond to immunotherapy).
🧭 Common pigment disorders (what to look for)
Concise entries on the most encountered pigmentary conditions with pathology and clinical clues.
Melasma
- Acquired patterned hyperpigmentation on the face; linked to hormones, sun exposure, genetics.
- Pathology: increased epidermal and/or dermal melanin with normal or increased melanocyte activity.
- Clinical tip: sun protection and topical lightening agents; recurrence common.
Post-inflammatory hyperpigmentation (PIH)
- Darkening after skin injury/inflammation (acne, eczema, burns).
- Pathology: increased melanin in epidermis and/or dermis (melanin incontinence).
- Management: treat underlying inflammation and use sunscreens/depigmenting agents.
Lentigo & lentiginous patterns
- Well-demarcated brown macules from increased melanocyte activity and melanin; solar lentigo linked to sun damage.
- Pathology: epidermal hyperpigmentation, increased melanocyte number in some lentigines.
Café-au-lait macules
- Uniform light-brown patches present from childhood; multiple lesions suggest neurofibromatosis type 1.
- Pathology: increased melanin with normal melanocyte number.
Freckles (ephelides)
- Small pigmented macules that darken with sun exposure; due to increased melanin per melanocyte rather than more melanocytes.
Nevi (melanocytic nevi) & lentigo maligna
- Benign melanocytic proliferations (junctional, compound, intradermal). Dysplastic nevi show architectural disorder and cytologic atypia — monitor or remove based on risk.
- Biopsy to distinguish benign nevi from melanoma, particularly for changing or irregular lesions.
Vitiligo
- Autoimmune depigmentation with complete loss of melanocytes leading to well-demarcated white patches.
- Pathology: absence of melanocytes and melanin in affected epidermis; perifollicular repigmentation is possible.
- Treatment: topical steroids, calcineurin inhibitors, phototherapy; early inflammatory lesions may respond best.
Albinism
- Genetic defects in melanin synthesis resulting in generalized hypopigmentation and ocular involvement.
- Pathology: normal melanocyte number with absent or markedly reduced melanin production.
Ochronosis / exogenous ochronosis
- Deep dermal brown–black pigment from ochronotic material or from prolonged topical hydroquinone misuse.
- Pathology: yellow-brown, banana-shaped pigment within dermis; hard to treat, prevention is key.
Drug- and metal-induced pigmentation
- Certain drugs (minocycline, antimalarials, amiodarone) and metals (silver, gold) can cause diffuse or localized pigmentation.
- Biopsy shows drug/metalloprotein deposits or associated melanosis/hemosiderin depending on cause.
Café-au-lait, linear/segmental and mosaic patterns
- Segmental or blaschkoid patterns suggest mosaicism or post-zygotic mutation; clinicopathologic correlation is important for syndromic associations.
Clinical tip: Distinguish loss of melanocytes (vitiligo, post-inflammatory hypopigmentation with melanocyte damage) from decreased melanin production or dermal melanosis — the difference guides prognosis and therapy.
🔬 Diagnosis — practical approach
Start with careful inspection, Wood's lamp exam, and patient history (onset, triggers, medications, family history). Use biopsy selectively to determine melanocyte status, pattern of pigment, or to rule out melanocytic neoplasia.
| Tool | When to use / Role |
|---|---|
| Wood's lamp | Enhances contrast in epidermal vs dermal pigmentation and helps identify vitiligo. |
| Skin biopsy (H&E + Melanocyte markers) | Shows melanocyte loss vs decreased melanin vs dermal pigment; use MART-1/HMB-45 for melanocyte assessment when needed. |
| Dermatoscopy | Helpful for nevi vs melanoma evaluation and for patterns in lentigo or lentiginous lesions. |
| Genetic testing | Consider for albinism or syndromic pigmentary disorders. |
Diagnostic pearl: Wood's lamp plus clinical distribution often answers epidermal vs dermal question; reserve biopsy for atypical lesions or when melanocytic proliferation is suspected.
🎯 Management — general principles
Management depends on cause: remove triggers and offending drugs, use sun protection, topical agents for hyperpigmentation, and targeted therapies for autoimmune depigmentation. Cosmetic procedures (peels, lasers) can be helpful in select stable cases but require expert selection.
Hyperpigmentation
- Address underlying inflammation; use sunscreens, topical hydroquinone/retinoids/azelaic acid; consider chemical peels or lasers for recalcitrant epidermal pigment.
Hypopigmentation / depigmentation
- Vitiligo: topical steroids/calcineurin inhibitors, NB-UVB phototherapy, and surgical grafting for stable focal disease; counseling on camouflage and sun protection important.
Critical: Any changing pigmented lesion (asymmetry, border irregularity, color variation, diameter >6 mm, evolution) requires prompt dermatologic assessment and possible excisional biopsy to exclude melanoma.
⚠️ Complications & prognosis
Most pigment disorders are chronic but benign; prognosis varies by cause. Melanoma risk is specific to melanocytic lesions; vitiligo may progress unpredictably; PIH can be long-lasting and psychologically impactful.
- Psychosocial impact is often significant — offer counseling and camouflage options.
- Prevention (sun protection, avoiding triggers) improves outcomes for many hyperpigmentation disorders.
Prognosis note: Identifying whether pigment change is epidermal, dermal or due to melanocyte loss is the single most useful predictor of treatment response.
🧠 Key takeaways
- Classify pigment disorders as hyperpigmentation, hypopigmentation/depigmentation, or exogenous pigment — this narrows diagnosis quickly.
- Wood's lamp, dermatoscopy and targeted biopsy (with melanocyte markers) clarify mechanism and guide therapy.
- Treat underlying inflammation, protect from sun, and select topical/phototherapy or procedural options based on depth and stability of pigment.
- Refer any suspicious or changing pigmented lesion for dermatologic evaluation to exclude melanoma.